AEGLEA BIOTHERAPEUTICS INC (AGLE) Stock Analyst Earnings Estimates
NASDAQ:AGLE - Nasdaq - US00773J2024 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.74M | 2.33M -87.57% | 1.292M -44.55% | 13.6M 952.63% | -100.00% | 71.4M | ||||||
| EBITDA YoY % growth | -80.48M -0.71% | -64.07M 20.39% | -83.21M -29.87% | -97.92M -17.68% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -81.48M -1.43% | -65.65M 19.43% | -84.78M -29.14% | -224.502M -164.81% | -73.95M 67.06% | -34.912M 52.79% | -255M -630.41% | -306M -20.00% | -357M -16.67% | -408M -14.29% | -479.4M -17.50% | |
| Operating Margin | N/A | -350.32% | -3,638.63% | -17,376.32% | -543.75% | N/A | N/A | N/A | N/A | N/A | -671.43% | |
| EPS YoY % growth | -1.61 34.29% | -8.44 -424.22% | -25.25 -199.17% | -5.43 78.51% | -2.36 56.52% | -3.98 -68.59% | -4.79 -20.51% | -5.56 -15.96% | -6.27 -12.84% | -6.94 -10.57% | -7.85 -13.24% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.93 79.37% | -0.68 86.43% | -0.49 98.82% | -0.74 92.03% | -0.53 42.86% |
| Revenue Q2Q % growth | 374.003K 120.00% | -100.00% | 10.2M 1,378.26% | 10.2M 2,627.25% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -35.224M -83.84% | -29.835M -58.61% | -20.91M 85.99% | -33.66M -1.26% | -25.245M 28.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -9.34 -96.63% | -0.86 | -8.48 | -983.65% |
| Q2 2023 Q2Q % growth | -41.50 -514.81% | -4.59 | -36.91 | -804.14% |
| Q1 2023 Q2Q % growth | -5.00 45.95% | -4.59 | -0.41 | -8.93% |
| Q4 2022 Q2Q % growth | -4.50 41.94% | -5.10 | 0.60 | 11.76% |
| Q3 2022 Q2Q % growth | -4.75 -1,432.26% | -5.92 | 1.17 | 19.71% |
| Q2 2022 Q2Q % growth | -6.75 -6,650.00% | -7.95 | 1.20 | 15.07% |
| Q1 2022 Q2Q % growth | -9.25 -3,203.57% | -8.59 | -0.66 | -7.75% |
| Q4 2021 Q2Q % growth | -7.75 -2,114.29% | -7.29 | -0.46 | -6.37% |
| Q3 2021 Q2Q % growth | -0.31 -6.90% | -0.28 | -0.03 | -9.10% |
| Q2 2021 Q2Q % growth | -0.10 75.00% | -0.17 | 0.07 | 40.33% |
| Q1 2021 Q2Q % growth | -0.28 50.88% | -0.17 | -0.11 | -61.48% |
| Q4 2020 Q2Q % growth | -0.35 46.15% | -0.31 | -0.04 | -11.29% |
| Q3 2020 Q2Q % growth | -0.29 56.06% | -0.40 | 0.11 | 27.37% |
| Q2 2020 Q2Q % growth | -0.40 27.27% | -0.45 | 0.05 | 11.16% |
| Q1 2020 Q2Q % growth | -0.57 3.39% | -0.67 | 0.10 | 14.68% |
| Q4 2019 Q2Q % growth | -0.65 | -0.69 | 0.04 | 6.01% |
| Q3 2019 Q2Q % growth | -0.66 | -0.55 | -0.11 | -19.09% |
| Q2 2019 Q2Q % growth | -0.55 | -0.50 | -0.05 | -10.80% |
| Q1 2019 Q2Q % growth | -0.59 | -0.57 | -0.02 | -3.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | 690K 9.52% | 690K | % | |
| Q1 2023 Q2Q % growth | 200K -85.29% | 125.123K | 74.877K | 59.84% |
| Q4 2022 Q2Q % growth | 170K -95.33% | 59.16K | 110.84K | 187.36% |
| Q3 2022 Q2Q % growth | 170K -87.86% | 212.497K | -42.497K | -20.00% |
| Q2 2022 Q2Q % growth | 630K -95.40% | 578.952K | 51.048K | 8.82% |
| Q1 2022 Q2Q % growth | 1.36M | 1.346M | 14K | 1.04% |
| Q4 2021 Q2Q % growth | 3.64M | 3.13M | 510K | 16.29% |
| Q3 2021 Q2Q % growth | 1.4M | 4.131M | -2.731M | -66.11% |
| Q2 2021 Q2Q % growth | 13.7M | 12.393M | 1.307M | 10.55% |
| Q1 2021 Q2Q % growth | 13.26M | -13.26M | -100.00% | |
| Q2 2019 Q2Q % growth | 306K | -306K | -100.00% | |
| Q1 2019 Q2Q % growth | 306K | -306K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 65.46% | -766.67% | 84.79% | -2071.43% |
| Revenue | N/A | N/A | 40.74% | 533.33% |